Olivier Molendi-Coste

Dr. Olivier Molendi-Coste

INSERM US41, Lille, Hauts-de-France, France
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
NLNicolas Lanthier
Nicolas Lanthier
OMOlivier Molendi-Coste
Olivier Molendi-Coste
YHYves Horsmans
Yves Horsmans
NRNico van Rooijen
Nico van Rooijen
Patrice CaniPatrice Cani
Patrice Cani
ILIsabelle A. Leclercq
Isabelle A. Leclercq
Recruited adipose tissue macrophages contribute to chronic and low-grade inflammation causing insulin resistance in obesity. Similarly, we hypothesized here that Kupffer cells, the hepatic resident macrophages, play a pathogenic role in hepatic insulin resistance induced by a high-fat diet. Mice were fed a normal diet or high-fat diet for 3 days. Kupffer cell activation was evaluated by immunohistochemistry and quantitative RT-PCR. Insulin sensitivity was assessed in vivo by hyperinsulinemic-euglycemic clamp and insulin-activated signaling was investigated by Western blot. Liposome-encapsulated clodronate was injected intravenously to deplete macrophages prior to a short-term exposure to high-fat diet. Here, we characterized a short-term high-fat diet model in mice and demonstrated early hepatic insulin resistance and steatosis concurrent with Kupffer cell activation. We demonstrated that selective Kupffer cell depletion obtained by intravenous clodronate, without affecting adipose tissue macrophages, was sufficient to enhance insulin-dependent insulin signaling and significantly improve hepatic insulin sensitivity in vivo in this short-term high-fat diet model. Our study clearly shows that hepatic macrophage response participates to the onset of high-fat diet-induced hepatic insulin resistance and may therefore represent an attractive target for prevention and treatment of diet- and obesity-induced insulin resistance.

8 December 2010 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
OMOlivier Molendi-Coste
Olivier Molendi-Coste
VLVanessa Legry
Vanessa Legry
ILIsabelle A. Leclercq
Isabelle A. Leclercq
Obesity and the metabolic syndrome are systemic inflammatory diseases reaching epidemic proportions. Contemporary changes in human nutrition occurred characterized by increased consumption of fat and of vegetable oils rich in n-6 polyunsaturated fatty acids (PUFAs) together with decrease in n-3 PUFA-rich foods, resulting in an n-6/n-3 ratio of 10–20/1 in Western diet for a ratio around 1/1 in the diet of our ancestors. The literature provides compelling evidence for the health benefit of n-3 PUFA consumption on inflammation and metabolic syndrome prevention and treatment. Such evidence led to the establishment of comprehensive recommendations. However, we show here that, both in collective catering proposed to children and in hospital diet, it is not straightforward to meet such recommendations. Willingness of governments to institute changes, with accountable decisions on catering, nutritional education, and food processing, is required to face our neglected responsibility in promoting balanced diet and consumption of foods rich in essential nutrients in the general population.

26 August 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
NLNicolas Lanthier
Nicolas Lanthier
OMOlivier Molendi-Coste
Olivier Molendi-Coste
Patrice CaniPatrice Cani
Patrice Cani
NRNico van Rooijen
Nico van Rooijen
YHYves Horsmans
Yves Horsmans
ILIsabelle A. Leclercq
Isabelle A. Leclercq
We aimed to evaluate activation of macrophages in insulin‐sensitive tissues (liver, adipose tissue, and muscles) under high‐fat diet (HFD) and elucidate the role of Kupffer cells (KC) in HFD‐induced insulin resistance. Tissue macrophage populations, insulin signaling, and sensitivity were evaluated in mice fed a HFD for 4 or 16 wk. Selective KC depletion was obtained by intravenous injections of liposome‐encapsulated clodronate. Mice fed a HFD for 4 to 16 wk have hepatic and peripheral insulin resistance together with macrophage recruitment in the adipose tissue but not in the liver. Depletion of KC for the last 10 d of the 16 wk experiment fails to improve insulin sensitivity compared to PBS‐treated animals. In contrast, preventive KC depletion prior to and during the 4 wk HFD attenuates the development of obesity, adiposity, adipose tissue inflammation ( P <0.01 vs . PBS group), and insulin resistance ( P <0.01). Interestingly, in mice fed a normal diet, prolonged KC depletion ameliorates insulin sensitivity and decreases adiposity without altering physiological body weight gain or food intake. Preventive and prolonged KC depletion ameliorates insulin sensitivity and prevents adipose tissue inflammation, suggesting a communication between the liver and the adipose tissue in the development of HFD‐induced metabolic alterations.—Lanthier, N., Molendi‐Coste, O., Cani, P. D., van Rooijen, N., Horsmans, Y., Leclercq, I. A. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet. FASEB J. 25, 4301–4311 (2011). www.fasebj.org

1 August 2007 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
Didier VieauDidier Vieau
Didier Vieau
NSNaima Sebaai
Naima Sebaai
MLMarion Léonhardt
Marion Léonhardt
IDIsabelle Dutriez-Casteloot
Isabelle Dutriez-Casteloot
OMOlivier Molendi-Coste
Olivier Molendi-Coste
Jean LesageJean Lesage
Jean Lesage

1 November 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LELaetitia Everaere
Laetitia Everaere
SASaliha Ait-Yahia
Saliha Ait-Yahia
OMOlivier Molendi-Coste
Olivier Molendi-Coste
HVHan Vorng
Han Vorng
SQSandrine Quemener
Sandrine Quemener
ATAnne Tsicopoulos
Anne Tsicopoulos

10 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BPBarbara D. Pachikian
Barbara D. Pachikian
AEAhmed Essaghir
Ahmed Essaghir
JDJean-Baptiste Demoulin
Jean-Baptiste Demoulin
ANAudrey Neyrinck
Audrey Neyrinck
ECEmilie Catry
Emilie Catry
Nathalie DelzenneNathalie Delzenne
Nathalie Delzenne
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsaturated fatty acid (PUFA) ratio in hepatic phospholipids. The metabolic consequences of n-3 PUFA depletion in the liver are poorly understood. We have reproduced a drastic drop in n-3 PUFA among hepatic phospholipids by feeding C57Bl/6J mice for 3 months with an n-3 PUFA depleted diet (DEF) versus a control diet (CT), which only differed in the PUFA content. DEF mice exhibited hepatic insulin resistance (assessed by euglycemic-hyperinsulinemic clamp) and steatosis that was associated with a decrease in fatty acid oxidation and occurred despite a higher capacity for triglyceride secretion. Microarray and qPCR analysis of the liver tissue revealed higher expression of all the enzymes involved in lipogenesis in DEF mice compared to CT mice, as well as increased expression and activation of sterol regulatory element binding protein-1c (SREBP-1c). Our data suggest that the activation of the liver X receptor pathway is involved in the overexpression of SREBP-1c, and this phenomenon cannot be attributed to insulin or to endoplasmic reticulum stress responses. In conclusion, n-3 PUFA depletion in liver phospholipids leads to activation of SREBP-1c and lipogenesis, which contributes to hepatic steatosis.